Skip to main content
. 2023 Jun 2;16:178. doi: 10.1186/s13071-023-05805-1

Table 3.

Concentrations of product active ingredients in chicken blood sample

Product DPT Repetitiona Nb Concentration (ng/ml)c Engorgementd Survival time (days)d
Fluralaner 3 1 2 43.05 2.0 3.5
2 1 4.45 3.0 3
3 3 LOQ 3.0 2
7 1 2 65.9 1.0 7.5
2 3 2.52 3.0 8.3
3 3 93.55 1.7 5.3
14 1 1 24.92 3.0 11
2 3 LOQ 1.7 10
3 2 5.40 3.0 11
28 1 2 LOQ 2.5 11
2 2 LOQ 2.5 11
3 3 LOQ 3.0 11
56 1 3 LOQ 2.7 11
2 3 LOQ 2.3 11
3 2 LOQ 2.0 11
Fenbendazole 3 1 3 LOQ 2.0 11
2 3 LOQ 2.0 11
3 3 LOQ 3.0 11
7 1 2 LOQ 2.0 11
2 2 LOQ 2.5 11
3 3 LOQ 3.0 11
14 1 2 LOQ 3.0 11
2 2 LOQ 2.0 11
3 3 LOQ 2.0 11
28 1 0 LOQ NAe NAe
2 3 LOQ 2.0 11
3 3 LOQ 2.0 11
56 1 2 LOQ 3.0 11
2 3 LOQ 3.0 11
3 1 LOQ 3.0 11

DPT Days post-treatment

aTotal of 3 repetitions of each trial

bNumber of triatomines that fed on chicken

cLOQ = less than the limit of quantification. Fluralaner: 2.5 ng/ml; fenbendazole: 5 ng/ml

dMean of the fed triatomines

eNot applicable; no triatomines took a blood meal from this chicken